Burning Rock Biotech Limited (BNR) Financials

BNR Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 160.0 million 41.6 million
2023-06-30 183.7 million 50.1 million
2023-03-31 231.4 million 62.5 million
2022-12-31 205.7 million 54.0 million

BNR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.5 million ?
2023-06-30 -10.9 million 5.2 million
2023-03-31 -18.9 million 47.6 million
2022-12-31 -16.4 million 11.3 million

BNR Net Income

No data available :(

BNR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 - - 2.6 million
2023-06-30 101.1 million - 4.2 million
2023-03-31 132.0 million - 6.0 million
2022-12-31 115.2 million - 7.4 million

BNR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 14.0 million
2023-06-30 14.1 million
2023-03-31 14.9 million
2022-12-31 14.9 million

BNR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 11.5 million 24.8 million -
2023-06-30 - 13.2 million 9.6 million 9.8 million
2023-03-31 9.0 million 14.7 million 19.3 million 12.4 million
2022-12-31 9.0 million 13.7 million 18.6 million 9.4 million

BNR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 17.5 million 5.7 million
2023-06-30 20.2 million 6.3 million
2023-03-31 20.7 million 6.0 million
2022-12-31 20.7 million 6.3 million

BNR

Price: $0.81

52 week price:
0.57
3.25

Earnings Per Share: -0.96 USD

P/E Ratio: -0.88

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 139800

Market Capitalization: 73.4 million

Links: